> Until now focused on evaluation in patients (they developped several tools and evaluation methods of neuromuscular function) Jean-Yves Hogrel and his team recently have extended their area to in vivo evaluations in animals.

> On the occasion of the 3rd Rare Disease Day, Stéphane Roques, Secretary General of the Institute of Myology, discusses the involvement of the Institute in research, teaching and management of these rare diseases that include neuromuscular diseases.

> David Sassoon is the Director of the U787-Myology Group (INSERM-UPMC-Association Institut de Myologie) at the Institute of Myology . His research focuses on stem cell regulators. In March he will publish an article on a new population of muscle resident interstitial cells that have very promising properties for cell therapy. Two teams from the group led the research: one directed by Giovanna Marazzi & David Sassoon, the other by Edgar Gomes.

> Sandrine Arbogast is post-doctoral researcher in Ana Ferreiro research group (U787). In July 2009, she published an original article in Annals of Neurology and a review in Antioxidants and Redox Signaling, articles about selenoproteins and protection against oxidative stress, in particular the role of selenoprotein N in myopathy related to SEPN1 (SEPN1-related myopathy or selenoproteinopathy.